• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过心脏植入式电子设备进行每日测量以评估健康状况。

Daily Measurements from Cardiac Implantable Electronic Devices to Assess Health Status.

作者信息

Roseboom Eva, Daniëls Fenna, Rienstra Michiel, Maass Alexander H

机构信息

Department of Cardiology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.

Department of Cardiology, Isala Hospital, 8025 AB Zwolle, The Netherlands.

出版信息

Diagnostics (Basel). 2024 Dec 6;14(23):2752. doi: 10.3390/diagnostics14232752.

DOI:10.3390/diagnostics14232752
PMID:39682659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640493/
Abstract

Cardiac implantable electronic devices (CIEDs) such as pacemakers and implantable cardioverter-defibrillators (ICDs) are increasingly used in the aging population. Modern CIEDs perform daily measurements, mainly aimed at discovering early signs of battery depletion or electrode dysfunction. Changes in thresholds, intracardiac signals, and pacing impedances can be caused by exacerbation of existing conditions or novel clinical problems. Pacing percentages and heart rate histograms can be used to optimize pacemaker programming, but can also be a measure of altered cardiac health status. Several measurements, such as thoracic impedance and patient activity, have been added to inform practitioners about worsening heart failure. In addition, remote monitoring of daily CIED measurements may accommodate for the prevention of the deterioration of clinical conditions. In this review, we discuss the evidence base of CIED algorithms and suggest how to use standard daily measurements to monitor the cardiac and extracardiac health status of patients with CIEDs.

摘要

心脏植入式电子设备(CIED),如起搏器和植入式心脏复律除颤器(ICD),在老年人群中的使用越来越广泛。现代CIED会进行日常测量,主要目的是发现电池耗尽或电极功能障碍的早期迹象。阈值、心内信号和起搏阻抗的变化可能由现有病情加重或新出现的临床问题引起。起搏百分比和心率直方图可用于优化起搏器编程,但也可作为心脏健康状况改变的一种衡量指标。已增加了多项测量,如胸阻抗和患者活动情况,以便向从业者通报心力衰竭的恶化情况。此外,对CIED日常测量进行远程监测可能有助于预防临床状况的恶化。在本综述中,我们讨论了CIED算法的证据基础,并建议如何利用标准日常测量来监测CIED患者的心脏和心脏外健康状况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/bd27ebed0af5/diagnostics-14-02752-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/61015a1915c3/diagnostics-14-02752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/708139755169/diagnostics-14-02752-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/66c36e023779/diagnostics-14-02752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/f76de506134e/diagnostics-14-02752-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/4afce0d2ac98/diagnostics-14-02752-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/bd27ebed0af5/diagnostics-14-02752-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/61015a1915c3/diagnostics-14-02752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/708139755169/diagnostics-14-02752-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/66c36e023779/diagnostics-14-02752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/f76de506134e/diagnostics-14-02752-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/4afce0d2ac98/diagnostics-14-02752-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/225c/11640493/bd27ebed0af5/diagnostics-14-02752-g006.jpg

相似文献

1
Daily Measurements from Cardiac Implantable Electronic Devices to Assess Health Status.通过心脏植入式电子设备进行每日测量以评估健康状况。
Diagnostics (Basel). 2024 Dec 6;14(23):2752. doi: 10.3390/diagnostics14232752.
2
Predicted longevity of contemporary cardiac implantable electronic devices: A call for industry-wide "standardized" reporting.预测当代心脏植入式电子设备的预期寿命:呼吁全行业“标准化”报告。
Heart Rhythm. 2018 Dec;15(12):1756-1763. doi: 10.1016/j.hrthm.2018.07.029. Epub 2018 Jul 29.
3
Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis.磁共振成像在非条件性起搏器和植入式心脏复律除颤器中的应用:系统评价和荟萃分析。
Europace. 2020 Feb 1;22(2):288-298. doi: 10.1093/europace/euz343.
4
Inappropriate shock incidence in patients with subcutaneous implantable cardioverter-defibrillators with concomitant cardiac implantable electronic devices: A single-center cohort study.皮下植入式心律转复除颤器联合心脏植入式电子装置患者的不适当电击发生率:一项单中心队列研究。
Pacing Clin Electrophysiol. 2024 Jan;47(1):131-138. doi: 10.1111/pace.14887. Epub 2023 Nov 27.
5
2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary.《2021年儿科患者心血管植入式电子设备适应证与管理的PACE专家共识声明:执行摘要》
Indian Pacing Electrophysiol J. 2021 Nov-Dec;21(6):349-366. doi: 10.1016/j.ipej.2021.07.006. Epub 2021 Jul 29.
6
Sudden Death in Patients With Cardiac Implantable Electronic Devices.心脏植入式电子设备患者的猝死。
JAMA Intern Med. 2015 Aug;175(8):1342-50. doi: 10.1001/jamainternmed.2015.2641.
7
A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy.一项针对直接暴露于 10Gy 以内时心脏植入式电子设备瞬态和永久性故障的随机体外评估。
Strahlenther Onkol. 2021 Mar;197(3):198-208. doi: 10.1007/s00066-020-01651-7. Epub 2020 Jun 19.
8
Thoracic versus nonthoracic MR imaging for patients with an MR nonconditional cardiac implantable electronic device.针对植入了磁共振非条件心脏植入式电子设备的患者进行胸部与非胸部磁共振成像对比研究
Pacing Clin Electrophysiol. 2018 Jun;41(6):589-596. doi: 10.1111/pace.13340. Epub 2018 Apr 30.
9
Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.欧洲心脏节律协会卫生经济学委员会关于欧洲心脏植入式电子设备远程监测的实施与报销情况调查
Europace. 2015 May;17(5):814-8. doi: 10.1093/europace/euu390. Epub 2015 Feb 20.
10
Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.心脏植入式电子设备治疗:永久性起搏器、植入式心脏复律除颤器和心脏再同步治疗装置。
Med Clin North Am. 2019 Sep;103(5):931-943. doi: 10.1016/j.mcna.2019.04.005. Epub 2019 Jul 5.

本文引用的文献

1
Future perspectives and challenges of artificial intelligence implementation in remote monitoring of cardiac implantable electronic devices.心脏植入式电子设备远程监测中人工智能应用的未来前景与挑战
Expert Rev Med Devices. 2024 Oct;21(10):887-888. doi: 10.1080/17434440.2024.2402891. Epub 2024 Sep 13.
2
Monitoring of Remotely Reprogrammable Implantable Loop Recorders With Algorithms to Reduce False-Positive Alerts.带有算法的远程程控可植入环路记录器的监测可减少假阳性警报。
J Am Heart Assoc. 2024 Mar 5;13(5):e032890. doi: 10.1161/JAHA.123.032890. Epub 2024 Feb 23.
3
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
阿哌沙班预防非瓣膜性心房颤动的卒中。
N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12.
4
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.在伴有心房快速发作的患者中使用依度沙班进行抗凝治疗。
N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062. Epub 2023 Aug 25.
5
Telemonitoring for heart failure: a meta-analysis.远程心力衰竭监测:一项荟萃分析。
Eur Heart J. 2023 Aug 14;44(31):2911-2926. doi: 10.1093/eurheartj/ehad280.
6
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic.2023 年 HRS/EHRA/APHRS/LAHRS 远程设备诊所实践管理专家共识声明
Europace. 2023 May 19;25(5). doi: 10.1093/europace/euad123.
7
Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide.在开始使用阿霉素和环磷酰胺进行化疗后,起搏器导线阻抗增加且起搏阈值升高。
HeartRhythm Case Rep. 2022 Sep 24;8(12):845-848. doi: 10.1016/j.hrcr.2022.09.011. eCollection 2022 Dec.
8
Association Between Device-Measured Physical Activity and Incident Heart Failure: A Prospective Cohort Study of 94 739 UK Biobank Participants.设备测量的身体活动与心力衰竭事件的相关性:英国生物库 94739 名参与者的前瞻性队列研究。
Circulation. 2022 Sep 20;146(12):883-891. doi: 10.1161/CIRCULATIONAHA.122.059663. Epub 2022 Aug 29.
9
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
10
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364.